Add Yahoo as a preferred source to see more of our stories on Google. The genetic testing service 23andMe has certainly been under fire over the years, including a data breach in 2023. Now, with the ...

Following a data breach and bankruptcy, genetic testing service 23andMe will soon be in different hands. On Monday, biotechnology company Regeneron announced that it won the top bid in a bankruptcy ...

(Reuters) -Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from ...

23andMe, the popular genetic testing service with DNA samples collected from millions of Americans, announced it is voluntarily filing for Chapter 11 bankruptcy. News of the pending bankruptcy came ...

You’re worth a fortune. I was sorry that 23andMe filed for Chapter 11 bankruptcy protection last week, but there would be a blizzard in Death Valley before I would ever use an online DNA kit company.

Add Yahoo as a preferred source to see more of our stories on Google. 23andMe Smith Collection/Gado/Getty Images The bankruptcy of personal genomics company 23andMe is a headline that has broken past ...

23andMe and its co-founder, Anne Wojcicki, aimed to revolutionize healthcare. Earlier this year, WSJ took a look at factors that knocked the company’s valuation down to nearly $0. Photo: Peter DaSilva ...

'I'm tired of being the product' You're worth a fortune. I was sorry that 23andMe filed for Chapter 11 bankruptcy protection last week, but there would be a blizzard in Death Valley before I would ...

Regeneron Pharmaceuticals has acquired 23andMe – and the genetic data for 15 million customers along with it. Credit: Tiffany Hagler-Geard/Bloomberg via Getty Images 23andMe had all the signs of a ...

The controversial DNA testing company, 23andMe, has recently filed for bankruptcy and is now looking to sell off its assets. Its CEO has also resigned from her post amidst the announcement. However, ...

CEO Anne Wojcicki announced today that 23andMe is working with drug maker GlaxoSmithKline (GSK) to develop new drugs and treatments with help from all that genetic data the company has on file. Share ...